Nyxoah Completed 115 Implants In Its Dream US Pivotal Study, Submitted First Module In Modular PMA And Implanted First Patient In Acccess US Pivotal Study.
Nyxoah SA (NASDAQ:NYXH) ("Nyxoah" or the "Company"), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA),